Elevance Health, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $199.1 | $177.0 | $171.3 | $156.6 | $138.6 |
| Operating income | $7.2 | $7.9 | $8.5 | $8.3 | $7.6 |
| Net income | $5.7 | $6.0 | $6.0 | $5.9 | $6.2 |
| Cash Flow Statement | |||||
| Free cash flow | $3.2 | $4.6 | $6.8 | $7.2 | $7.3 |
| Dividends | $1.5 | $1.5 | $1.4 | $1.2 | $1.1 |
| Share repurchases | $2.6 | $2.9 | $2.7 | $2.3 | $1.9 |
Shares outstanding 216.9M · Free float 99.8%
Annual filing data through FY ended December 31, 2025; float as of September 26, 2026.